Brief: ABVC Biopharma- Got Written Notification From Nasdaq, Indicating Co Regained Compliance With Listing Rules 5635(A)(1) And 5635(A)(2)
Sept 10 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA- GOT WRITTEN NOTIFICATION FROM NASDAQ,
INDICATING
CO REGAINED COMPLIANCE WITH LISTING RULES 5635(A)(1) AND
5635(A)(2)
Source text for Eikon: ID:n0001213900-24-077361
Further company coverage: ABVC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21
NASDAQ RESUMED AT 09:05 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:43 PM
Brief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon